publication date: Aug. 3, 2010In this issue: Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System. Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.